Gene therapy with modified autologous hematopoietic stem cells
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Gene therapy with modified autologous hematopoietic stem cells, covering 2025-12-09 to 2025-12-09. Get the full timeline:
Most recent: Clinical Trial Update: Gene Therapy With Modified Autologous Hematopoietic Stem Cells for the Treatment of Patients With Mucopolysaccharidosis Type I, Hurler Variant [Phase 1, Phase 2]